| Source HCPCS Code |
|
Target NDC Code |
C9142
Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
|
⇄
|
70121-1754-01
ALYMSYS 100 MG/4 ML VIAL
|
| Detail Information |
| Relationship Start Date |
10/01/2022 |
| Relationship End Date |
12/31/2022 |
| Number Of Items In Ndc Package |
4 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
C9142
Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
|
⇄
|
70121-1755-01
ALYMSYS 400 MG/16 ML VIAL
|
| Detail Information |
| Relationship Start Date |
10/01/2022 |
| Relationship End Date |
12/31/2022 |
| Number Of Items In Ndc Package |
16 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|